These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 724314)

  • 1. Age-dependent closure of the patent ductus arteriosus by indomethacin.
    McCarthy JS; Zies LG; Gelband H
    Pediatrics; 1978 Nov; 62(5):706-12. PubMed ID: 724314
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oral ibuprofen and indomethacin for treatment of patent ductus arteriosus in premature infants: a randomized trial at Ramathibodi Hospital.
    Supapannachart S; Limrungsikul A; Khowsathit P
    J Med Assoc Thai; 2002 Nov; 85 Suppl 4():S1252-8. PubMed ID: 12549803
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oral ibuprofen in early curative closure of patent ductus arteriosus in very premature infants.
    Cherif A; Jabnoun S; Khrouf N
    Am J Perinatol; 2007 Jun; 24(6):339-45. PubMed ID: 17564958
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Consequences of delayed surgical closure of patent ductus arteriosus in very premature infants.
    Jaillard S; Larrue B; Rakza T; Magnenant E; Warembourg H; Storme L
    Ann Thorac Surg; 2006 Jan; 81(1):231-4. PubMed ID: 16368371
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Indomethacin therapy in premature infants of advanced postnatal age.
    Achanti B; Pyati S; Yeh TF
    J Perinatol; 1987; 7(3):235-7. PubMed ID: 3504463
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of oral ibuprofen and indomethacin therapy for patent ductus arteriosus in preterm infants.
    Fakhraee SH; Badiee Z; Mojtahedzadeh S; Kazemian M; Kelishadi R
    Zhongguo Dang Dai Er Ke Za Zhi; 2007 Oct; 9(5):399-403. PubMed ID: 17937843
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effectiveness and side effects of an escalating, stepwise approach to indomethacin treatment for symptomatic patent ductus arteriosus in premature infants below 33 weeks of gestation.
    Sperandio M; Beedgen B; Feneberg R; Huppertz C; Brüssau J; Pöschl J; Linderkamp O
    Pediatrics; 2005 Dec; 116(6):1361-6. PubMed ID: 16322159
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A comparison of oral ibuprofen and intravenous indomethacin for closure of patent ductus arteriosus in preterm infants.
    Chotigeat U; Jirapapa K; Layangkool T
    J Med Assoc Thai; 2003 Aug; 86 Suppl 3():S563-9. PubMed ID: 14700149
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Closure of the ductus arteriosus in premature infants by inhibition of prostaglandin synthesis.
    Heymann MA; Rudolph AM; Silverman NH
    N Engl J Med; 1976 Sep; 295(10):530-3. PubMed ID: 950959
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical profile and management of symptomatic patent ductus arteriosus in premature infants.
    Shenoi A; Narang A; Bhakoo ON; Bidwai PS
    Indian Pediatr; 1991 Feb; 28(2):125-30. PubMed ID: 2055626
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacologic management of patent ductus arteriosus.
    Bhatt V; Nahata MC
    Clin Pharm; 1989 Jan; 8(1):17-33. PubMed ID: 2643499
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High efficacy and minor renal effects of indomethacin treatment during individualized fluid intake in premature infants with patent ductus arteriosus.
    Leonhardt A; Strehl R; Barth H; Seyberth HW
    Acta Paediatr; 2004 Feb; 93(2):233-40. PubMed ID: 15046280
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ibuprofen lysine for the prevention and treatment of patent ductus arteriosus.
    Pai VB; Sakadjian A; Puthoff TD
    Pharmacotherapy; 2008 Sep; 28(9):1162-82. PubMed ID: 18752387
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effects of indomethacin on renal function and intracranial hemorrhage in infants with patent ductus arteriosus.
    Davis JM; Hendricks-Munoz KD; Hagberg D; Manning JA
    Dev Pharmacol Ther; 1990; 14(1):15-9. PubMed ID: 2311476
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neonatal necrotizing enterocolitis with intestinal perforation in extremely premature infants receiving early indomethacin treatment for patent ductus arteriosus.
    Fujii AM; Brown E; Mirochnick M; O'Brien S; Kaufman G
    J Perinatol; 2002; 22(7):535-40. PubMed ID: 12368968
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Indomethacin-induced early patent ductus arteriosus closure cannot be predicted by a decrease in pulse pressure.
    Lubetzky R; Mandel D; Mimouni FB; Diamant S; Birger A; Barak M; Dollberg S
    Am J Perinatol; 2004 Jul; 21(5):257-61. PubMed ID: 15232757
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Closure of Botallo's ductus arteriosus with indomethacin. Considerations on 4 cases].
    Raponi S; Crippa R; Pagani G; Stival G; Petrone M
    Pediatr Med Chir; 1982; 4(6):643-8. PubMed ID: 6927415
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Controlled trial of intravenous lyophilized indomethacin in the treatment of persistent ductus arteriosus in premature infants].
    Monset-Couchard M; Dias-Mançano D; Murat I; Relier JP
    Pediatrie; 1983 Sep; 38(6):365-77. PubMed ID: 6364030
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment strategies to prevent or close a patent ductus arteriosus in preterm infants and outcomes.
    Laughon M; Bose C; Clark R
    J Perinatol; 2007 Mar; 27(3):164-70. PubMed ID: 17251985
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Indomethacin responsiveness of patent ductus arteriosus and renal abnormalities in preterm infants treated with indomethacin.
    Itabashi K; Ohno T; Nishida H
    J Pediatr; 2003 Aug; 143(2):203-7. PubMed ID: 12970633
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.